Globus Medical Inc
GMED· NYSE
Released Aug 7, 2025, after the close
10-Q filed Aug 7, 2025, 38 days after period end · 0001562762-25-000200
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $745.34M | $629.69M | $291.62M | $263.65M |
| Net Income | $202.85M | $31.76M | $57.71M | $54.59M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $1.49 |
| $0.23 |
| $0.57 |
| $0.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.